Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingen Zhu

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|February 7, 2026
Cryo-EM structures of bacteriophage T4 portal-neck assembly intermediates reveal a viral genome retention mechanismLin Han, Qiyu Mao, Jingen Zhu, et al.
Iscience|December 11, 2025
Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line modelsHimanshu Batra, Jingen Zhu, Swati Jain, et al.
Frontiers in Immunology|July 12, 2017
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, <i>Bacillus anthracis</i> and <i>Yersinia pestis</i>Pan Tao, Marthandan Mahalingam, Jingen Zhu, et al.
Nature Communications|February 20, 2026
In situ structures of the portal-neck-tail complex of bacteriophage T4 inform a viral genome positioning mechanismAndrei Fokine, Jingen Zhu, Thomas Klose, et al.
Antiviral Research|July 29, 2023
T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccinesMengling Li, Cen Chen, Xialin Wang, et al.
Small Science|July 14, 2025
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal VaccinesJingen Zhu, Jian Sha, Himanshu Batra, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR EngineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Science Advances|September 13, 2021
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Mbio|July 28, 2022
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 VaccineJingen Zhu, Swati Jain, Jian Sha, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|February 7, 2026
Cryo-EM structures of bacteriophage T4 portal-neck assembly intermediates reveal a viral genome retention mechanismLin Han, Qiyu Mao, Jingen Zhu, et al.
Iscience|December 11, 2025
Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line modelsHimanshu Batra, Jingen Zhu, Swati Jain, et al.
Frontiers in Immunology|July 12, 2017
A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, <i>Bacillus anthracis</i> and <i>Yersinia pestis</i>Pan Tao, Marthandan Mahalingam, Jingen Zhu, et al.
Nature Communications|February 20, 2026
In situ structures of the portal-neck-tail complex of bacteriophage T4 inform a viral genome positioning mechanismAndrei Fokine, Jingen Zhu, Thomas Klose, et al.
Antiviral Research|July 29, 2023
T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccinesMengling Li, Cen Chen, Xialin Wang, et al.
Small Science|July 14, 2025
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal VaccinesJingen Zhu, Jian Sha, Himanshu Batra, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR EngineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Science Advances|September 13, 2021
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Mbio|July 28, 2022
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 VaccineJingen Zhu, Swati Jain, Jian Sha, et al.
Pageof 3